Biotechnology - Genomic and Proteomics/IP Profile of Biggest for-profit companies in BGP: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 11: | Line 11: | ||
{| class="prettytable" | {| class="prettytable" | ||
| | | | ||
| '''2006 Revenue ($m) | | '''2006 Revenue ($m)''' | ||
| Headquarters | | '''Headquarters''' | ||
| Primary Outputs | | '''Primary Outputs''' | ||
| Instances of Commons-based approaches''' | | '''Instances of Commons-based approaches''' | ||
Revision as of 12:12, 15 March 2009
Answer the questions:
- What are the 10 biggest for-profit companies in this field?
- How is the market distributed?
- Where are they located? Are there any incentives for specific locations?
- Correlate them with their main outputs (Data. Narratives. Tools)
- Understand and identify cases where these companies are “experimenting” or “adopting” commons-based approaches
- Identify these cases and treat them as entities that will also be placed in our mapping*device (the quadrants)
- Identify what companies are the “Microsofts” of the field and what companies are the “IBMs” of the field
2006 Revenue ($m) | Headquarters | Primary Outputs | Instances of Commons-based approaches
| |
Amgen | 14268
|
Thousand Oaks, California | ten approved drugs for 15 conditions, 23 agents are being tested earlier in the approval pipeline | ? |
Genentech
|
9284
|
South San Francisco
|
synthetic human insulin âÃì their first famous product, many others produced using the Boyer-Cohen rDNA process | ? |
Genzyme
|
3187
|
Cambridge, Massachusetts
|
Cerezyme (treats Gaucher's disease) accounts for 30% of company's revenue | ? |
Gilead Sciences
|
3026
|
Foster City, California | 11 commercial products
|
? |
Biogen Idec
|
2683
|
Cambridge, Massachusetts
|
Treatments for Crohn's disease, non-Hodgkin's lymphoma, and multiple sclerosis | ? |
Cephalon
|
1764
|
Frazer, Pennsylvania | Specializes in treating neurodegenerative diseases | ? |
MedImmune
|
1277
|
Gaithersburg, Maryland | Only major drug prevents respiratory diseases in infants | ? |
Celgene
|
899
|
Summit, New Jersey
|
treatments for erythema nodosum leprosum ("ENL") and multiple myeloma | ? |
Abraxis BioScience
|
766
|
Los Angeles, California
|
uses patented nanoparticle technology to produce products for metastatic breast cancer | ? |
ImClone Systems
|
678
|
New York, New York
|
acquired by Eli Lilly, tried to produce Erbitux for Colorectal Cancer, but failed to win FDA approval | ? |